Table 1.
Group 1 | Group 2 | ||
EEPVI + interpulmonary isthmus ablation | EEPVI | p Value | |
n=100 | n=100 | ||
Age (years) | 63±11 | 62±11 | 0.75 |
Female | 34 | 28 | 0.44 |
Associated disease | |||
Heart failure | 8 | 5 | 0.57 |
Hypertension | 41 | 53 | 0.09 |
Diabetes | 8 | 15 | 0.18 |
TIA/stroke | 8 | 5 | 0.57 |
AF conditions | |||
Duration of AF (years) | 3±2 | 3±2 | 1 |
CHADS2 score | 0.8±0.8 | 0.9±0.8 | 0.81 |
CHA2DS2-VASc score | 1.7±1.4 | 1.6±1.2 | 0.71 |
Echocardiographic parameters | |||
LVEF (%) | 65±7 | 64±8 | 0.83 |
LA diameter (mm) | 39±4 | 38±5 | 0.94 |
Because the total number of patients in each group was 100, the number also indicates the percentage. Values are mean±SD.
AF, atrial fibrillation; EEPVI, extensive encircling pulmonary vein isolation; LA, left atrium; LVEF, left ventricular ejection fraction; TIA, transient ischaemic attack